How to Control Fasting Blood Sugar

Target Values

1. Lifestyle Modifications (First-Line for All)

Diet

• Reduce refined carbohydrates and added sugars - these spike post-meal glucose and contribute to overnight fasting hyperglycemia
• High-fiber diet - slows glucose absorption; multiple studies show improved glycemic control
• Low glycemic index foods - whole grains, legumes, non-starchy vegetables
• Avoid late-night eating - eating close to bedtime raises morning (fasting) glucose
• Calorie restriction if overweight - even modest weight loss (5-7% body weight) substantially improves insulin sensitivity

Exercise

• Exercise is a cornerstone of diabetes management (Rosen's Emergency Medicine)
• Both aerobic and resistance training lower fasting glucose by increasing GLUT4 translocation in muscle
• A 2025 meta-analysis (PMID 40818268) confirmed resistance training significantly improves glycemic control, particularly in women with type 2 diabetes
• Aim for at least 150 minutes of moderate aerobic activity per week

Intermittent Fasting / Time-Restricted Eating

• A 2025 meta-analysis (PMID 40806442) found time-restricted eating improves glycemic control in type 2 diabetes - this directly lowers fasting glucose by giving the body longer periods without glucose influx

Sleep and Stress

• Poor sleep and chronic stress raise cortisol, which drives hepatic gluconeogenesis and raises fasting glucose
• Aim for 7-8 hours of quality sleep per night

Weight Loss

• Visceral fat causes insulin resistance; losing abdominal fat directly lowers fasting glucose
• In type 2 diabetes, high fasting glucose is largely driven by the liver overproducing glucose when it is resistant to insulin's suppressive effects (Goodman & Gilman's)

2. Medications

First-Line: Metformin

• Most widely used first-line oral agent
• Works primarily by reducing hepatic glucose output (gluconeogenesis) - this is why it specifically targets fasting glucose
• Dose: usually 500 mg once or twice daily, titrated up
• Also improves insulin sensitivity in muscle and fat
• Well-tolerated; main side effect is GI upset (extended-release formulation is better tolerated)

Sulfonylureas (e.g., Glipizide, Glyburide)

• Stimulate the pancreas to secrete more insulin by blocking ATP-sensitive K+ channels in beta cells
• Lower both fasting and post-meal glucose
• Risk of hypoglycemia; avoid in elderly or those with erratic eating
• Glipizide 5 mg once daily or Glyburide 2.5-5 mg once daily

SGLT-2 Inhibitors (e.g., Empagliflozin, Canagliflozin)

• Block glucose reabsorption in the kidney; glucose is excreted in urine
• Lower fasting glucose and carry cardiovascular/renal benefits
• Preferred in patients with heart failure or chronic kidney disease

GLP-1 Receptor Agonists (e.g., Semaglutide, Liraglutide)

• Injected (or oral semaglutide available)
• Suppress glucagon, slow gastric emptying, promote satiety
• Significant weight loss benefit alongside glucose lowering

Thiazolidinediones (e.g., Pioglitazone)

• Improve insulin sensitivity in muscle and fat
• Can be added if metformin alone is insufficient

Insulin

• Used in type 1 diabetes (mandatory) and in advanced type 2 diabetes
• Long-acting basal insulin (e.g., insulin glargine) given at bedtime specifically targets fasting hyperglycemia by suppressing overnight hepatic glucose production

3. Monitoring

• Check fasting glucose (after 8+ hours without food, before breakfast)
• Target: 90-130 mg/dL for most adults with diabetes (Lippincott Pharmacology)
• HbA1c < 7% is the overall 3-month average target
• Continuous glucose monitors (CGM) allow real-time tracking across fasting and feeding periods

Practical Summary

Note: This is general medical information. Your specific treatment plan should be tailored by your doctor based on your HbA1c, kidney function, cardiovascular risk, and other factors.